Home World News Presence of Tumour and Higher Levels of LAG3-positive T-cells in the Blood... World News Presence of Tumour and Higher Levels of LAG3-positive T-cells in the Blood May Be Necessary to Derive Clinical Benefit with Nivolumab Plus Relatlimab Over Nivolumab in Melanoma By Ogkologos - November 11, 2025 385 0 Facebook Twitter Google+ Pinterest WhatsApp Primary results of RELATIVITY-098 and translational evidence from RELATIVITY-098 and RELATIVITY-047 studies Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR From Awareness to Action: Putting Cancer Disparities in the Rearview Mirror March 21, 2024 EMA Recommends Extension of Therapeutic Indications for Durvalumab to Patients with... August 2, 2024 Pembrolizumab Continues to Demonstrate Durable Efficacy with No New Safety Signals... January 17, 2023 Persistent Poverty Linked to Increased Risk of Dying from Cancer November 19, 2020 Load more HOT NEWS Final Results of the Collaborative EORTC/Intergroup Randomised Phase III Study of... ΝΕΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ ESMO Announces Results of 2025 Elections Cancer Survivor with Strong Family History Was Denied Regular Screening Because...
